ADVISORY, Feb. 9, 2009 (GLOBE NEWSWIRE) -- What: Glenn A. Oclassen, President and Chief Executive Officer, will preside over the Opening Bell to commemorate Transcept Pharmaceuticals’ listing on The NASDAQ Stock Market.
ADVISORY, Feb. 9, 2009 (GLOBE NEWSWIRE) -- What: Glenn A. Oclassen, President and Chief Executive Officer, will preside over the Opening Bell to commemorate Transcept Pharmaceuticals’ listing on The NASDAQ Stock Market.
